157 articles in this topic
Researchers discover unique molecular patterns in lipedema patients and develop predictive models for this poorly understood condition affecting women.
Large-scale protein analysis enhanced diabetes risk prediction by 23-29%, offering new tools for early prevention strategies.
New study shows CGMs improve blood sugar control and birth outcomes compared to traditional glucose testing during pregnancy.
NIH study identifies metabolic mechanism behind controversial skin condition and demonstrates successful treatment with mitochondrial complex I inhibitors.
New research reveals promising outcomes for patients with severe liver cirrhosis who successfully stop drinking alcohol.
New research reveals fatty liver disease follows circadian patterns linked to insulin resistance and reduced nighttime insulin availability.
New research reveals how glucose metabolism directly controls fat tissue expansion through a novel epigenetic pathway involving JMJD1A.
Scientists discover how FGF21 fights liver disease through a key protein, opening new treatment paths for metabolic dysfunction.
New research identifies choline kinase alpha as a key driver of diabetic retinopathy and microvascular dysfunction.
Large-scale study identifies three key blood proteins that predict diabetic retinopathy development with 90% accuracy.
Large NHANES study reveals metabolic syndrome causes measurable acceleration in epigenetic aging clocks, offering new targets for intervention.
FDA-integrated CGMs provide superior accuracy and safety compared to non-approved devices flooding global markets.
